BRAF and colorectal carcinoma: Owing to the rarity of the KRAS/BRAF double mutation, the clinicopathological and molecular characteristics of KRAS/BRAF double-mutant tumors and differences in the biology of KRAS or BRAF single-mutant CRC and KRAS/BRAF double-mutant CRC remain unknown.